CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.0% | +80.9% | +58.9% | +2.3% | +2.3% | +17.4% | +3.7% | +5.5% | -1.8% | +16.7% | -7.5% | – | |
| – | +5.1% | +15.8% | +40.8% | -4.2% | +3.8% | +8.7% | +27.6% | -13.1% | -4.3% | +36.6% | -16.2% | – | |
| – | +71.0% | -67.6% | +248.3% | -101.3% | – | – | – | -122.6% | – | -382.6% | – | – | |
| – | -73.3% | +42.5% | -28.3% | -44.7% | +94.9% | +20.4% | +158.4% | -73.0% | -46.9% | +79.0% | -36.5% | – | |
| – | -54.8% | – | -17,459.5% | – | -2,731.1% | -84.1% | – | +334.2% | -65.3% | -541.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -88.8% | +937.8% | -98.1% | +635.1% | +901.9% | -99.2% | +59.0% | -56.3% | +744.2% | +1,397.5% | -97.7% | – | |
| – | -185.1% | – | -127.5% | – | -449.0% | – | – | – | -117.3% | – | -559.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.